Oncimmune Holdings (UK) Probability of Future Stock Price Finishing Over 30.12
| ONC Stock | 14.90 0.10 0.68% |
Oncimmune |
Oncimmune Holdings Target Price Odds to finish over 30.12
The tendency of Oncimmune Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move over 30.12 or more in 90 days |
| 14.90 | 90 days | 30.12 | close to zero percent |
Based on a normal probability distribution, the odds of Oncimmune Holdings to move over 30.12 or more in 90 days from now is close to zero percent (This Oncimmune Holdings plc probability density function shows the probability of Oncimmune Stock to fall within a particular range of prices over 90 days) . Probability of Oncimmune Holdings plc price to stay between its current price of 14.90 and 30.12 at the end of the 90-day period is about 76.55 .
Assuming the 90 days trading horizon Oncimmune Holdings has a beta of 0.23. This indicates as returns on the market go up, Oncimmune Holdings average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Oncimmune Holdings plc will be expected to be much smaller as well. Additionally Oncimmune Holdings plc has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Oncimmune Holdings Price Density |
| Price |
Predictive Modules for Oncimmune Holdings
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Oncimmune Holdings plc. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Oncimmune Holdings Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Oncimmune Holdings is not an exception. The market had few large corrections towards the Oncimmune Holdings' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Oncimmune Holdings plc, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Oncimmune Holdings within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.19 | |
β | Beta against Dow Jones | 0.23 | |
σ | Overall volatility | 0.87 | |
Ir | Information ratio | -0.06 |
Oncimmune Holdings Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Oncimmune Holdings for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Oncimmune Holdings plc can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Oncimmune Holdings generated a negative expected return over the last 90 days | |
| Oncimmune Holdings has high historical volatility and very poor performance | |
| Oncimmune Holdings has a very high chance of going through financial distress in the upcoming years | |
| The company reported the revenue of 1.15 M. Net Loss for the year was (6.15 M) with profit before overhead, payroll, taxes, and interest of 1.46 M. | |
| Oncimmune Holdings generates negative cash flow from operations | |
| About 20.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from news.google.com: Oncimmune Holdings Sees Change in Major Shareholder Voting Rights - TipRanks |
Oncimmune Holdings Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Oncimmune Stock often depends not only on the future outlook of the current and potential Oncimmune Holdings' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Oncimmune Holdings' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 72.5 M | |
| Cash And Short Term Investments | 3.2 M |
Oncimmune Holdings Technical Analysis
Oncimmune Holdings' future price can be derived by breaking down and analyzing its technical indicators over time. Oncimmune Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Oncimmune Holdings plc. In general, you should focus on analyzing Oncimmune Stock price patterns and their correlations with different microeconomic environments and drivers.
Oncimmune Holdings Predictive Forecast Models
Oncimmune Holdings' time-series forecasting models is one of many Oncimmune Holdings' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Oncimmune Holdings' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Oncimmune Holdings plc
Checking the ongoing alerts about Oncimmune Holdings for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Oncimmune Holdings plc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Oncimmune Holdings generated a negative expected return over the last 90 days | |
| Oncimmune Holdings has high historical volatility and very poor performance | |
| Oncimmune Holdings has a very high chance of going through financial distress in the upcoming years | |
| The company reported the revenue of 1.15 M. Net Loss for the year was (6.15 M) with profit before overhead, payroll, taxes, and interest of 1.46 M. | |
| Oncimmune Holdings generates negative cash flow from operations | |
| About 20.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from news.google.com: Oncimmune Holdings Sees Change in Major Shareholder Voting Rights - TipRanks |
Other Information on Investing in Oncimmune Stock
Oncimmune Holdings financial ratios help investors to determine whether Oncimmune Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Oncimmune with respect to the benefits of owning Oncimmune Holdings security.